Arteris Inc
For the period ended Dec 31, 2023. Filed Feb 20, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 20, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
(a) Not applicable
(b) Insider Trading Arrangements
On February 27, 2023 the Company adopted an insider trading policy governing the purchase, sale, and other dispositions of its securities by directors, senior management, and employees.
On November 10, 2023, Wayne Cantwell, Director, terminated a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) and originally adopted on March 6, 2023 for the sale of up to 71,161 shares of the Company’s common stock until June 30, 2024.
On November 13, 2023, Antonio Viana, Director, as the trustee of Viana Family Trust, adopted a Rule 10b5-1 trading arrangement of Viana Family Trust that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 227,777 shares of the Company’s common stock until April 30, 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.